As the Israeli parliament passes its first budget in over three and a half years, there are many companies this week that have had no problem ratcheting up the numbers. 

Japanese tech giant, SoftBank bought a stake in OurCrowd, one of Israel’s most active venture capital firms, with White & Case leading. In fact, OurCrowd was one of the investors in the USD 250 million Series E financing carried out by Israeli small business management platform HoneyBook, which doubled its valuation. In biotech, Immunai closed a major investment from Koch Disruptive Technologies, with Herzog  Fox & Neeman leading, while Yigal Arnon acted for GK8 in its acquisition by Celsius in the fintech space. Gornitzky  advised Group 11  as the first VC fund listed on the TASE UP platform.

An IVC-Meitar report reveals interesting stats on valuations of Israeli companies that went public and those that raised capital privately and IsraelDesks adds the Israeli law firms advising the 31 unicorns that raised capital this year.

Elsewhere, Erdinast, Ben Nathan, Toledano & Co. With Hamburger Evron and Herrick, Feinstein LLP discussed large-scale infrastructure projects in Israel and the U.S., and McDermott Will & Emery’s U.S. partners will shortly host a key webinar on the rocketing number of SPACs. Pearl Cohen welcomes two new partners as expansion gathers pace. 

Click here to read the weekly roundup: